Industry
Biotechnology
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 27, 2024 | 12:53 pm
Portfolio Pulse from Benzinga Newsdesk
July 29, 2024 | 12:47 pm
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 12:32 pm
Portfolio Pulse from Ananya Gairola
June 13, 2024 | 5:51 am
Portfolio Pulse from Benzinga Newsdesk
June 10, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
June 07, 2024 | 8:32 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 2:22 pm
Portfolio Pulse from Benzinga Insights
May 17, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 12:35 pm
Portfolio Pulse from Benzinga Insights
May 10, 2024 | 4:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.